Bandingkan Harga & Kinerja Paninvest Tbk. (PNIN) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Paninvest Tbk. dan Organon Pharma Indonesia Tbk.: Paninvest Tbk. diperdagangkan di Rp725 (kapitalisasi pasar 2,93 T, volume 24 jam 435,7 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Paninvest Tbk. jauh lebih besar — sekitar 28,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PNIN | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 2,93 T | 104,4 M |
Volume | 435,7 rb | — |
Lot | 4,36 rb | — |
Perputaran | 315,34 jt | — |
Harga Rata-rata | 723,75 | — |
Nilai Transaksi | 315,34 jt | — |
Harga Ekuilibrium Indikatif | 725 | — |
Volume Ekuilibrium Indikatif | 1 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Paninvest Tbk.
PT Paninvest Tbk formerly PT Panin Insurance Tbk (the Company) was established in Jakarta under the name PT Pan-Union Insurance Ltd., based on Notarial Deed No. 84 dated October 24, 1973 of Notary Juliaan Nimrod Siregar Gelar Mangaradja Namora, S.H. The Company is one of the companies under Pan Indonesia (Panin) Group. Based on the Minutes of General Shareholders's Meeting held on June 28, 2013 which was notarized in Notarial Deed of Kumala Tjahjani Widodo, S.H., M.H.,Mkn., No.78, dated June 28, 2013, the shareholders agree the plan to change the Company's main business activity from general insurance company to tourism and transferred its general insurance portfolio along with portion of its assets and liabilities related to general insurance business to PT Asuransi Umum Panin, subsidiary.
Selengkapnya di halaman PNIN →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
